Ligand of Numb Protein X 4 (LNX4) is a member of the LNX family, proteins known for their roles in ubiquitination and signal transduction, contributing to the regulation of various cellular processes including proliferation, differentiation, and apoptosis. LNX proteins typically function as E3 ubiquitin ligases, catalyzing the transfer of ubiquitin from an E2 conjugating enzyme to target proteins, marking them for degradation or altering their activity and localization. LNX4, through its interactions and ubiquitination activity, is implicated in the modulation of signaling pathways critical for neurogenesis and the maintenance of neural progenitor cells. Its function underscores the intricate regulation of cellular signaling networks necessary for precise developmental processes and the maintenance of cellular homeostasis. Given the pivotal role of ubiquitination in cellular regulation, LNX4's activity is fundamental in orchestrating the turnover and activity of key proteins within these signaling cascades.
The activation of LNX4 involves a complex interplay of molecular interactions and post-translational modifications that facilitate its E3 ligase activity. The protein's activation is likely influenced by its binding to specific substrates or partner proteins, which can induce conformational changes enhancing its ligase activity or specificity. Additionally, post-translational modifications such as phosphorylation may regulate LNX4's function, affecting its stability, subcellular localization, or interaction with E2 conjugating enzymes and substrates. The precise mechanisms of LNX4 activation are integral to understanding its role in cellular signaling and the maintenance of cellular functions. These activation processes ensure that LNX4 can respond dynamically to cellular signals and environmental cues, modulating the ubiquitination and degradation of target proteins in a context-dependent manner. This regulation is crucial for the fine-tuning of signaling pathways that govern cell fate decisions and tissue homeostasis, highlighting the significance of LNX4 in cellular physiology and signaling networks.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
MG132 is a proteasome inhibitor that can affect ubiquitin-mediated protein degradation, potentially influencing LNX4-related pathways. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Bortezomib, another proteasome inhibitor, might impact ubiquitination processes relevant to LNX4 functions. | ||||||
Ubiquitin E1 Inhibitor, PYR-41 | 418805-02-4 | sc-358737 | 25 mg | $360.00 | 4 | |
PYR-41 is a ubiquitin-activating enzyme inhibitor, potentially influencing ubiquitination pathways associated with LNX4. | ||||||
CFTR Inhibitor-172 | 307510-92-5 | sc-204680 sc-204680A | 10 mg 50 mg | $165.00 $510.00 | 10 | |
SMER3 enhances autophagy, a process interconnected with ubiquitination, potentially affecting LNX4 activity. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Curcumin can modulate various cellular signaling pathways, potentially impacting LNX4-related processes. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Resveratrol affects several signaling pathways, which might indirectly influence LNX4 functions. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
EGCG has multiple cellular effects and could influence signaling pathways relevant to LNX4. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin increases cAMP levels, potentially influencing signaling pathways related to LNX4 activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin inhibits mTOR, affecting cell growth and signaling, which might be relevant to LNX4 function. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium Chloride affects the Wnt signaling pathway, potentially impacting LNX4-related processes. | ||||||